This site may require a log-in in the near future. We are constantly being swamped by AI agents. If they continue to take down the site, we will be changing to requiring logins to access any item.

Dosages for Lacticaseibacillus paracasei shirota {Yakult}

LcS

🍽️ More information

The dosages below are from completed studies on humans or on clinical trials on humans. In general, they represent safe dosages for most people. Please be aware that there is often an exponentail effectiveness. Talking half the dosage may only see 1/4 of the effect. We are not looking at minimum effective dosage, but maximum [safe] dosage used in clinical trials and studies.

If a study has been completed, the dosage will be marked Ineffective or Effective -- depending if statistically changes were reported by the study.

This is not medical advice (see your MD for that). It is a reporting on dosages that some MDs have used.
Look up dosages for other substances

Suggestions for Lacticaseibacillus paracasei shirota {Yakult}
Study Clinical Study Dosage Effective
. Effects of Lactobacillus Casei on Respiratory and Gastrointestinal Diseases in Adults 1000   mcfu/day
. Effect of Lactobacillus Casei DG (Enterolactis Plus®) in Patient With Irritable Bowel Syndrome: a Pilot Study 48000   mcfu/day
. L. Casei DG® in Patients With Irritable Bowel Syndrome. (PROBE2) 48000   mcfu/day
. Effect of Lactobacillus Casei Shirota on the Small Intestinal Microbiota (ROBIN) (ROBIN) 6500   mcfu/day
. Effect of Glucomannan Supplementation on Body Weight in Overweight and Obese Children 3000   mg/day
. Glucomannan Effects on Children With Non-alcoholic Fatty Liver Disease (GC-NASH) 5000   mg/day
. Glucomannan for the Treatment of Abdominal Pain-related Functional Gastrointestinal Disorders in Childhood 10000   mg/day
. Obesity - Inflammation - Metabolic Disease: Effect of Lactobacillus Casei Shirota 3   bottles of Yakult
. Obesity - Inflammation - Metabolic Disease: Effect of Lactobacillus Casei Shirota 2000   MCFU
. The Effect of Probiotic Supplementation 13000   MCFU

Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.

Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served.   Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA   Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license.   Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models.   Inventions /Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]